In addition to taking care of patients with lymphoma and CLL, Dr. Danilov initiates and leads clinical trials and heads a research laboratory which investigates novel therapeutic targets in lymphoma. Importantly, in collaboration with industry, his research team translates bench discoveries into early-phase clinical trials, which are poised to improve lives of patients by developing safe and effective new treatments. Dr. Danilov is a Lymphoma Research Foundation Clinical Investigator and a Knight Research Scholar. He and his research team are recipients of numerous awards, including the Leukemia and Lymphoma Society Translational Research Program Award, American Society of Hematology Abstract Achievement Award, Gazzaniga Family Prize, Professor Albitski Prize and others. His research is consistently featured at national and international meetings.